Myomo Competitors

MYO Stock  USD 0.87  0.03  3.57%   
Myomo Inc competes with Modular Medical, Hyperion DeFi, Vicarious Surgical, Precision Optics, and Neuroone Medical; as well as few others. The company runs under Health Care Equipment & Supplies sector within Health Care industry. Analyzing Myomo competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Myomo to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Myomo Correlation with its peers.

Myomo vs India Globalization Correlation

Good diversification

The correlation between Myomo Inc and IGC is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Myomo Inc and IGC in the same portfolio, assuming nothing else is changed.

Moving against Myomo Stock

  0.52BKRKY Bank RakyatPairCorr
  0.41MASI MasimoPairCorr
  0.38OTC Ocumetics Technology CorpPairCorr
  0.37AHC Austco HealthcarePairCorr
As of the 2nd of February 2026, Return On Tangible Assets is likely to drop to -0.14. In addition to that, Return On Capital Employed is likely to drop to -0.18. At this time, Myomo's Total Assets are very stable compared to the past year. As of the 2nd of February 2026, Net Tangible Assets is likely to grow to about 7.7 M, while Other Assets are likely to drop about 589.3 K.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Myomo's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.845.71
Details
Intrinsic
Valuation
LowRealHigh
0.091.856.72
Details
Naive
Forecast
LowNextHigh
0.010.755.62
Details
5 Analysts
Consensus
LowTargetHigh
4.555.005.55
Details

Myomo Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Myomo and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Myomo and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Myomo Inc does not affect the price movement of the other competitor.

High positive correlations

IGCNXL
RBOTHYPD
NXLRBOT
IGCRBOT
IGCMLSS
NXLHYPD
  

High negative correlations

MIRAPOCI
ECORMIRA
NXLNMTC
NXLECOR
MLSSNMTC
IGCNMTC

Risk-Adjusted Indicators

There is a big difference between Myomo Stock performing well and Myomo Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Myomo's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MODD  4.68 (0.03) 0.00  0.06  0.00 
 10.42 
 45.40 
HYPD  6.24 (1.08) 0.00 (0.41) 0.00 
 13.58 
 34.90 
RBOT  4.81 (1.35) 0.00 (0.47) 0.00 
 11.90 
 36.01 
POCI  1.99  0.26  0.10  0.25  2.30 
 3.68 
 27.89 
NMTC  3.62  0.11  0.04  0.08  3.81 
 9.59 
 23.46 
MIRA  2.23 (0.44) 0.00 (0.76) 0.00 
 3.25 
 15.08 
ECOR  3.91  0.51  0.14  0.26  3.69 
 10.17 
 31.20 
MLSS  3.42 (0.68) 0.00 (0.76) 0.00 
 7.41 
 23.59 
NXL  3.95 (1.40) 0.00 (0.45) 0.00 
 7.92 
 27.45 
IGC  2.72 (0.64) 0.00 (0.60) 0.00 
 6.06 
 25.10 

Cross Equities Net Income Analysis

Compare Myomo Inc and related stocks such as Modular Medical, Hyperion DeFi, and Vicarious Surgical Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
MODD(30 K)(17.5 K)(20.8 K)(22.8 K)(31 K)(31.1 K)(106.6 K)(106.6 K)(2.5 M)(5.3 M)(7.4 M)(18.6 M)(13.9 M)(17.5 M)(18.8 M)(16.9 M)(16.1 M)
HYPD(19.8 M)(19.8 M)(19.8 M)(19.8 M)(19.8 M)(19.8 M)(19.8 M)(19.8 M)(19.8 M)(19.8 M)(19.8 M)(12.8 M)(28 M)(27.3 M)(49.8 M)(44.8 M)(42.6 M)
RBOT(9.3 M)(9.3 M)(9.3 M)(9.3 M)(9.3 M)(9.3 M)(9.3 M)(9.3 M)(9.3 M)(9.3 M)(12.9 M)(35.2 M)5.2 M(71.1 M)(63.2 M)(56.9 M)(54.1 M)
POCI200 K961 K(1.8 M)(1.2 M)(1.2 M)(1 M)(1 M)(351.4 K)(614.9 K)(1.4 M)(102.8 K)(928.4 K)(144.6 K)(3 M)(5.8 M)(5.2 M)(4.9 M)
NMTC(6 K)(14 K)(14 K)(30.6 K)(36.2 K)(62.9 K)(47.8 K)(6.8 M)(6.8 M)(13.6 M)(9.9 M)(10 M)(11.9 M)(12.3 M)(3.6 M)(3.2 M)(3.4 M)
MIRA(68 K)(68 K)(68 K)(68 K)(68 K)(68 K)(68 K)(68 K)(68 K)(68 K)(68 K)(2.2 M)(7.1 M)(12 M)(7.9 M)(7.1 M)(7.4 M)
ECOR(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.7 M)(35.8 M)(55.8 M)(45.1 M)(23.5 M)(17.2 M)(22.2 M)(18.8 M)(11.9 M)(13.7 M)(14.4 M)
MLSS(1.9 M)(1.5 M)(870.3 K)1.5 M(1.7 M)(5.5 M)(5.9 M)(5.2 M)(7.4 M)(7.5 M)(7.3 M)(6.8 M)(8.7 M)(6.9 M)(4.7 M)(4.2 M)(4.5 M)
NXL(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(3.4 M)(6.1 M)(1.7 M)(4.6 M)(7.6 M)(6.8 M)(7.2 M)
IGC91.9 K(7.8 M)(2.3 M)(3 M)(4.6 M)(2.8 M)(1.9 M)(1.8 M)(4.1 M)(7.3 M)(8.8 M)(15 M)(11.5 M)(13 M)(7.1 M)(6.4 M)(6.7 M)

Myomo Inc and related stocks such as Modular Medical, Hyperion DeFi, and Vicarious Surgical Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Myomo Inc financial statement analysis. It represents the amount of money remaining after all of Myomo Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Myomo Competitive Analysis

The better you understand Myomo competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Myomo's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Myomo's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MYO MODD HYPD RBOT POCI NMTC MIRA ECOR MLSS NXL
 3.57 
 0.87 
Myomo
 0.22 
 0.45 
Modular
 20.45 
 4.24 
Hyperion
 0.91 
 2.18 
Vicarious
 0.99 
 4.98 
Precision
 0.56 
 0.88 
Neuroone
 0.80 
 1.24 
MIRA
 6.20 
 6.66 
Electrocore
 6.67 
 0.28 
Milestone
 0.000002 
 0.57 
Nexalin
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Myomo Competition Performance Charts

Five steps to successful analysis of Myomo Competition

Myomo's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Myomo Inc in relation to its competition. Myomo's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Myomo in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Myomo's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Myomo Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Myomo position

In addition to having Myomo in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cryptocurrency ETFs Thematic Idea Now

Cryptocurrency ETFs
Cryptocurrency ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Cryptocurrency ETFs theme has 123 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out Myomo Correlation with its peers.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Will Health Care Equipment & Supplies sector continue expanding? Could Myomo diversify its offerings? Factors like these will boost the valuation of Myomo. Expected growth trajectory for Myomo significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Myomo data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.28)
Revenue Per Share
1.015
Quarterly Revenue Growth
0.096
Return On Assets
(0.29)
Return On Equity
(1.01)
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Myomo's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Myomo represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Myomo's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.